Published in Transl Androl Urol on September 01, 2017
Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios. Transl Androl Urol (2016) 66.58
Cigarette Smoking and Semen Quality: A New Meta-analysis Examining the Effect of the 2010 World Health Organization Laboratory Methods for the Examination of Human Semen. Eur Urol (2016) 1.21
Bibliometrics: tracking research impact by selecting the appropriate metrics. Asian J Androl (2016) 0.94
Smoking and Male Infertility: An Evidence-Based Review. World J Mens Health (2015) 0.84
Proteomic signatures of infertile men with clinical varicocele and their validation studies reveal mitochondrial dysfunction leading to infertility. Asian J Androl (2016) 0.79
Evaluation of ureteroscopy outcome in a teaching hospital. Turk J Urol (2016) 0.75
Effect of urine pH on the effectiveness of shock wave lithotripsy: A pilot study. Urol Ann (2016) 0.75
Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology. Int J Reprod Med (2017) 0.75
The world's contribution to the field of urology in 2015: A bibliometric study. Arab J Urol (2016) 0.75
Reactive oxygen species and sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
It is high time for clinical application of sperm DNA fragmentation testing. Transl Androl Urol (2017) 0.75
Risk factors associated with sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
Epididymal contribution to male infertility: An overlooked problem. Andrologia (2020) 0.75
The debate on sperm DNA fragmentation test goes on. Transl Androl Urol (2017) 0.75
Restoration of fertility potential via targeted treatment approach. Transl Androl Urol (2017) 0.75
Future direction in sperm DNA fragmentation testing. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation in clinical practice. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation test results reflect the overall quality of the whole semen specimen. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation for the evaluation of male infertility: clinical algorithms. Transl Androl Urol (2017) 0.75
Development of treatment strategies in men with vulnerable sperm. Transl Androl Urol (2017) 0.75
An evidence-based perspective on the role of sperm chromatin integrity and sperm DNA fragmentation testing in male infertility. Transl Androl Urol (2017) 0.75
All-round approach in diagnosis. Transl Androl Urol (2017) 0.75
Live birth must be the primary reproductive endpoint in IVF/ICSI studies evaluating sperm DNA fragmentation testing. Transl Androl Urol (2017) 0.75
Best practice statements are not intended to dictate an exclusive course of management. Transl Androl Urol (2017) 0.75
Comparison of strategies to reduce sperm DNA fragmentation in couples undergoing ICSI. Transl Androl Urol (2017) 0.75
Current limitation and future perspective of sperm DNA fragmentation tests. Transl Androl Urol (2017) 0.75
Insights on the predictive accuracy of the sperm DNA fragmentation tests on male infertility. Transl Androl Urol (2017) 0.75
Clinical utility of sperm DNA fragmentation testing: concise practice recommendations. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation: laboratory and clinical aspects. Transl Androl Urol (2017) 0.75
Call for wider application of sperm DNA fragmentation test. Transl Androl Urol (2017) 0.75
From bench to clinic. Transl Androl Urol (2017) 0.75
Technical aspects of sperm DNA fragmentation testing, methods to select sperm with low DNA fragmentation, and usefulness of redox potential measurement in male infertility. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation testing is on the right track. Transl Androl Urol (2017) 0.75
An update on the techniques used to measure oxidative stress in seminal plasma. Andrologia (2020) 0.75
Development of targeted therapeutic strategies and refinement of sperm DNA fragmentation testing. Transl Androl Urol (2017) 0.75
Laboratory tests for oxidative stress. Indian J Urol (2017) 0.75
Use of sperm DNA fragmentation testing and testicular sperm for intracytoplasmic sperm injection. Transl Androl Urol (2017) 0.75
The price and value of sperm DNA fragmentation tests. Transl Androl Urol (2017) 0.75
Expanding our understanding of clinical laboratory testing in male infertility patients. Transl Androl Urol (2017) 0.75
Elucidating the clinical indications of sperm DNA fragmentation in male infertility. Transl Androl Urol (2017) 0.75
The value of sperm DNA fragmentation testing in real-life clinical presentations. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation: a key player in decision making. Transl Androl Urol (2017) 0.75
Antioxidant therapy in idiopathic oligoasthenoteratozoospermia. Indian J Urol (2017) 0.75
Understanding sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation: overcoming standardization obstacles. Transl Androl Urol (2017) 0.75
Further evidence supports the clinical utility of sperm DNA fragmentation testing in male infertility workup and assisted reproductive technology. Transl Androl Urol (2017) 0.75
The correct interpretation of sperm DNA fragmentation test. Transl Androl Urol (2017) 0.75
Integrating surgical and clinical andrology is essential to improve the quality of care delivered to infertile couples. Transl Androl Urol (2017) 0.75
The complex nature of the sperm DNA damage process. Transl Androl Urol (2017) 0.75
Despite limitations, sperm DNA fragmentation testing provides unique information complementary to but distinct from semen analysis results. Transl Androl Urol (2017) 0.75
A single cut-off value of sperm DNA fragmentation testing does not fit all. Transl Androl Urol (2017) 0.75
One of the many missing links between infertility and sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation testing reveals the overall quality of a semen sample. Transl Androl Urol (2017) 0.75
The role of female factors in the management of sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation: a rationale for its clinical utility. Transl Androl Urol (2017) 0.75
Unraveling the utility and limitations of clinical practice guidelines. Transl Androl Urol (2017) 0.75
The problem of mixing 'apples and oranges' in meta-analytic studies. Transl Androl Urol (2017) 0.75
Drawbacks of the current practice. Transl Androl Urol (2017) 0.75
Implication of sperm processing during assisted reproduction on sperm DNA integrity. Transl Androl Urol (2017) 0.75
Antioxidants for elevated sperm DNA fragmentation: a mini review. Transl Androl Urol (2017) 0.75
Frontiers in clinical andrology. Transl Androl Urol (2017) 0.75
Expanding treatment paradigm of high sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
Is National Institute of Clinical Excellence (NICE) guideline a nice guideline? Transl Androl Urol (2017) 0.75
More good than harm should be expected when Testi-ICSI is applied to oligozoospermic men with post-testicular sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
A Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis on the clinical utility of sperm DNA fragmentation testing in specific male infertility scenarios. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation testing: a cross sectional survey on current practices of fertility specialists. Transl Androl Urol (2017) 0.75
The missing piece in management of infertile couple-clinical andrology. Transl Androl Urol (2017) 0.75
The Society for Translational Medicine: clinical practice guidelines for sperm DNA fragmentation testing in male infertility. Transl Androl Urol (2017) 0.75
The importance of quality control and quality assurance in SDF testing. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation testing in patients with subclinical varicocele: is there any evidence? Transl Androl Urol (2017) 0.75